171 related articles for article (PubMed ID: 20711735)
1. BNP controls early load-dependent regulation of SERCA through calcineurin.
Toischer K; Teucher N; Unsöld B; Kuhn M; Kögler H; Hasenfuss G
Basic Res Cardiol; 2010 Nov; 105(6):795-804. PubMed ID: 20711735
[TBL] [Abstract][Full Text] [Related]
2. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
[TBL] [Abstract][Full Text] [Related]
3. Elevated afterload, neuroendocrine stimulation, and human heart failure increase BNP levels and inhibit preload-dependent SERCA upregulation.
Toischer K; Kögler H; Tenderich G; Grebe C; Seidler T; Van PN; Jung K; Knöll R; Körfer R; Hasenfuss G
Circ Heart Fail; 2008 Nov; 1(4):265-71. PubMed ID: 19808301
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
5. Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease.
de Boer RA; Henning RH; Suurmeijer AJ; Pinto YM; Olthof E; Kirkels JH; van Gilst WH; Crijns HJ; van Veldhuisen DJ
Int J Cardiol; 2001 Mar; 78(1):5-12. PubMed ID: 11259807
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
7. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
8. β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
Tauscher S; Nakagawa H; Völker K; Werner F; Krebes L; Potapenko T; Doose S; Birkenfeld AL; Baba HA; Kuhn M
Cardiovasc Diabetol; 2018 Jul; 17(1):103. PubMed ID: 30016962
[TBL] [Abstract][Full Text] [Related]
9. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
[TBL] [Abstract][Full Text] [Related]
10. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
11. Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction.
Vinet L; Rouet-Benzineb P; Marniquet X; Pellegrin N; Mangin L; Louedec L; Samuel JL; Mercadier JJ
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H352-60. PubMed ID: 18487442
[TBL] [Abstract][Full Text] [Related]
12. FKBP12.6 mice display temporal gender differences in cardiac Ca(2+)-signalling phenotype upon chronic pressure overload.
Prévilon M; Pezet M; Semprez F; Mercadier JJ; Rouet-Benzineb P
Can J Physiol Pharmacol; 2011 Nov; 89(11):769-82. PubMed ID: 22007848
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes.
Tanaka T; Kanda T; Takahashi T; Saegusa S; Moriya J; Kurabayashi M
J Int Med Res; 2004; 32(1):57-61. PubMed ID: 14997707
[TBL] [Abstract][Full Text] [Related]
14. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
15. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
Kishimoto I; Hamra FK; Garbers DL
Can J Physiol Pharmacol; 2001 Aug; 79(8):715-22. PubMed ID: 11558680
[TBL] [Abstract][Full Text] [Related]
16. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
17. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM
Life Sci; 2021 May; 272():119223. PubMed ID: 33610574
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
19. Transcription of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase type 3 gene, ATP2A3, is regulated by the calcineurin/NFAT pathway in endothelial cells.
Hadri L; Pavoine C; Lipskaia L; Yacoubi S; Lompré AM
Biochem J; 2006 Feb; 394(Pt 1):27-33. PubMed ID: 16250893
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.
Horikawa YT; Panneerselvam M; Kawaraguchi Y; Tsutsumi YM; Ali SS; Balijepalli RC; Murray F; Head BP; Niesman IR; Rieg T; Vallon V; Insel PA; Patel HH; Roth DM
J Am Coll Cardiol; 2011 May; 57(22):2273-83. PubMed ID: 21616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]